Metropolitan Life Insurance Company (MetLife)’s Analog Devices ADI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,998
| Closed | -$3.96M | – | 45 |
|
|
2024
Q1 | $3.96M | Sell |
19,998
-285
| -1% | -$54.8K | 0.17% | 106 |
|
|
2023
Q4 | $4.03M | Sell |
20,283
-463
| -2% | -$82.7K | 0.19% | 99 |
|
|
2023
Q3 | $3.63M | Sell |
20,746
-1,298
| -6% | -$239K | 0.19% | 97 |
|
|
2023
Q2 | $4.29M | Sell |
22,044
-627
| -3% | -$116K | 0.21% | 90 |
|
|
2023
Q1 | $4.47M | Sell |
22,671
-6,510
| -22% | -$1.17M | 0.23% | 86 |
|
|
2022
Q4 | $4.79M | Sell |
29,181
-1,765
| -6% | -$276K | 0.21% | 95 |
|
|
2022
Q3 | $4.31M | Sell |
30,946
-575
| -2% | -$90.9K | 0.2% | 98 |
|
|
2022
Q2 | $4.6M | Sell |
31,521
-897
| -3% | -$141K | 0.2% | 97 |
|
|
2022
Q1 | $5.35M | Sell |
32,418
-38,970
| -55% | -$6.31M | 0.19% | 102 |
|
|
2021
Q4 | $12.5M | Sell |
71,388
-1,444
| -2% | -$256K | 0.17% | 101 |
|
|
2021
Q3 | $12.2M | Buy |
72,832
+25,699
| +55% | +$4.31M | 0.18% | 101 |
|
|
2021
Q2 | $8.11M | Sell |
47,133
-363
| -0.8% | -$58.2K | 0.11% | 138 |
|
|
2021
Q1 | $7.37M | Sell |
47,496
-2,481
| -5% | -$381K | 0.11% | 150 |
|
|
2020
Q4 | $7.38M | Sell |
49,977
-1,867
| -4% | -$248K | 0.11% | 149 |
|
|
2020
Q3 | $6.05M | Sell |
51,844
-2,171
| -4% | -$254K | 0.1% | 155 |
|
|
2020
Q2 | $6.62M | Sell |
54,015
-2,925
| -5% | -$321K | 0.12% | 147 |
|
|
2020
Q1 | $5.1M | Sell |
56,940
-323
| -0.6% | -$35.3K | 0.1% | 161 |
|
|
2019
Q4 | $6.81M | Sell |
57,263
-565
| -1% | -$63.7K | 0.11% | 164 |
|
|
2019
Q3 | $6.46M | Sell |
57,828
-331
| -0.6% | -$37.5K | 0.11% | 162 |
|
|
2019
Q2 | $6.56M | Buy |
58,159
+4,033
| +7% | +$437K | 0.11% | 162 |
|
|
2019
Q1 | $5.7M | Sell |
54,126
-2,142
| -4% | -$215K | 0.1% | 168 |
|
|
2018
Q4 | $4.83M | Buy |
56,268
+101
| +0.2% | +$8.74K | 0.1% | 178 |
|
|
2018
Q3 | $5.19M | Sell |
56,167
-1,885
| -3% | -$181K | 0.09% | 195 |
|
|
2018
Q2 | $5.57M | Sell |
58,052
-15,617
| -21% | -$1.47M | 0.09% | 192 |
|
|
2018
Q1 | $6.71M | Buy |
73,669
+899
| +1% | +$81.9K | 0.09% | 171 |
|
|
2017
Q4 | $6.48M | Sell |
72,770
-117,261
| -62% | -$10.4M | 0.09% | 174 |
|
|
2017
Q3 | $16.4M | Sell |
190,031
-1,831
| -1% | -$148K | 0.1% | 171 |
|
|
2017
Q2 | $14.9M | Buy |
191,862
+11,626
| +6% | +$924K | 0.1% | 184 |
|
|
2017
Q1 | $14.8M | Buy |
180,236
+26,241
| +17% | +$2.06M | 0.1% | 187 |
|
|
2016
Q4 | $11.2M | Sell |
153,995
-3,566
| -2% | -$242K | 0.08% | 234 |
|
|
2016
Q3 | $10.2M | Sell |
157,561
-1,092
| -0.7% | -$67.7K | 0.07% | 253 |
|
|
2016
Q2 | $8.99M | Sell |
158,653
-16,221
| -9% | -$929K | 0.07% | 278 |
|
|
2016
Q1 | $10.4M | Sell |
174,874
-3,389
| -2% | -$181K | 0.08% | 236 |
|
|
2015
Q4 | $9.86M | Sell |
178,263
-4,509
| -2% | -$265K | 0.08% | 251 |
|
|
2015
Q3 | $10.3M | Sell |
182,772
-3,056
| -2% | -$178K | 0.07% | 242 |
|
|
2015
Q2 | $11.9M | Buy |
185,828
+7,188
| +4% | +$466K | 0.08% | 233 |
|
|
2015
Q1 | $11.3M | Sell |
178,640
-2,058
| -1% | -$117K | 0.08% | 242 |
|
|
2014
Q4 | $10M | Sell |
180,698
-2,811
| -2% | -$144K | 0.07% | 277 |
|
|
2014
Q3 | $9.08M | Sell |
183,509
-2,760
| -1% | -$141K | 0.07% | 293 |
|
|
2014
Q2 | $10.1M | Sell |
186,269
-7,385
| -4% | -$391K | 0.07% | 275 |
|
|
2014
Q1 | $10.3M | Sell |
193,654
-2,119
| -1% | -$107K | 0.07% | 277 |
|
|
2013
Q4 | $9.97M | Sell |
195,773
-2,758
| -1% | -$134K | 0.07% | 283 |
|
|
2013
Q3 | $9.34M | Buy |
198,531
+222
| +0.1% | +$10.6K | 0.07% | 282 |
|
|
2013
Q2 | $8.94M | Buy |
+198,309
| New | +$8.93M | 0.07% | 281 |
|
Other funds holding ADI
Metropolitan Life Insurance Company (MetLife)'s ADI Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Analog Devices (ADI) in Q2 2024, closing a stake of 19,998 shares — an estimated $3.96M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ADI in Q2 2013 and held it in 44 quarters. The position peaked at $16.4M in Q3 2017. 1,659 funds tracked by Wall St. Rank hold ADI as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Analog Devices position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 19,998 Analog Devices shares in Q2 2024, an estimated $3.96M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Analog Devices in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Analog Devices position peaked at $16.4M in Q3 2017.
- 1,659 funds tracked by Wall St. Rank held Analog Devices as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.